A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice
Eric M. Green(Maze (United States)), Christine E. Seidman(Harvard University), Héctor M. Rodrı́guez(Fluidigm (United States)), Jonathan G. Seidman(Harvard University), William Wan(University of Colorado Boulder), James A. Spudich(Stanford University), Robert S. McDowell(Fluidigm (United States)), Hiroko Wakimoto(Brigham and Women's Hospital), Brooke C. Harrison(University of Colorado Boulder), Johan D. Oslob(Fluidigm (United States)), Raja Kawas(Fluidigm (United States)), Leslie A. Leinwand(University of Colorado Boulder), Yonghong Song(Fluidigm (United States)), Marcus Henze(Fluidigm (United States)), Joshua Gorham(Harvard University), Robert L. Anderson(Fluidigm (United States)), Marc Evanchik(Fluidigm (United States))
Cited by 710
Related Papers
Contemporary Definitions and Classification of the Cardiomyopathies
|Circulation|2006|3.4k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Circulation|2011|2.1k
Cells of the adult human heart
|Nature|2020|1.8k
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2003|1.6k